Ginkgo Bioworks Inc.

NYSE: DNA · Real-Time Price · USD
13.15
0.25 (1.94%)
At close: Aug 15, 2025, 3:59 PM
13.30
1.14%
After-hours: Aug 15, 2025, 06:24 PM EDT

Ginkgo Bioworks Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-547.03M -892.87M -2.11B -1.84B
Depreciation & Amortization
63.02M 71.55M 44.42M 29.08M
Stock-Based Compensation
112.34M 229.88M 1.93B 1.61B
Other Working Capital
-89.72M -19.05M -81.35M 55.43M
Other Non-Cash Items
142.69M 266.89M -69.28M -20.95M
Deferred Income Tax
-936K -801K -14.61M 30.21M
Change in Working Capital
-89.67M 29.84M -37.01M -61.54M
Operating Cash Flow
-319.58M -295.5M -252.2M -253.82M
Capital Expenditures
-62.54M -40.8M -52.27M -56.52M
Cash Acquisitions
-5.4M -38.55M 26.65M -12.04M
Purchase of Investments
n/a n/a -3.69M -5M
Sales Maturities Of Investments
4.52M n/a n/a n/a
Other Investing Acitivies
1.19M -1.34M -38.08M 304K
Investing Cash Flow
-62.24M -80.69M -67.39M -73.26M
Debt Repayment
-897K -1.29M -1.24M -1.12M
Common Stock Repurchased
n/a -23K n/a -25M
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-922K -1.43M -1.5M 1.56B
Financial Cash Flow
-1.74M -3.22M 95.34M 1.53B
Net Cash Flow
-383.84M -380M -223.35M 1.21B
Free Cash Flow
-382.13M -336.3M -304.47M -310.34M